Research!America has developed several series of one-page reports to highlight the benefits of research to improve health.
To find what you're looking for, click on one of the icons:
To illustrate the social and economic impact of medical and health research, we established the Investment in Research Saves Lives and Money series in partnership with the Mary Woodard Lasker Charitable Trust. Each page focuses on one or a set of conditions or health topics and includes current statistics, examples of cost- and life-saving benefits of research and the story of a patient who has thrived or survived thanks to research.
Traumatic Brain Injury (TBI)
Multiple Sclerosis (MS)
Hip Fractures & Osteoporosis
Heart Disease & Stroke
State-based fact sheets
Global health R&D benefits states across the country in terms of job creation and health impact. Learn about how each of these states benefits from global health R&D investment:California
Agency fact sheets
Five different federal agencies have a hand in global health R&D. To learn more about each agency's contribution, public-private partnerships, recent progress and the public's opinion, see our fact sheets below.
Introductory Agency Fact Sheet
The National Institutes of Health
The Centers for Disease Control and Prevention
Department of Defense
The United States Agency for International Development
The Food and Drug Administration
Milestones in Global Health
Research and development has led to innovative treatments and therapies for patients around the world. Our milestones in global health pamphlet charts the breakthroughs in HIV, malaria, TB, meningitis and a host of other diseases.
Neglected Tropical Diseases
Despite their name, neglected tropical diseases aren't limited to tropical locales; they're affecting people across the southern tier of the United States, from California east to South Carolina. Fortunately, research is taking place across the country to battle NTDs. Our fact sheets detail that research and how it's making a difference both in the U.S. and around the world.
One of those NTDs, Chagas disease, affects five times as many Latin Americans as HIV/AIDS. Chagas is a threat to the U.S. as well; Chagas-related heart failure among the current U.S. patient population costs our country nearly $1 billion per year. Research currently being done in the U.S. is leading to vaccines, promising treatments and a better understanding of Chagas transmission. Learn more with our Chagas fact sheet.
This fact sheet highlights NIH-funded research and innovation conducted in Georgia. The biosciences industry plays a pivotal role in Georgia’s economy and promises to be a key driver of state growth in future years.
This report highlights contributions by the private and public sectors engaged in genomics research that are translating their work into clinical applications. As a direct impact of the Human Genome Project, important advances in genomics research are benefiting patients, adding substantially to the economy, and creating jobs. Therefore, the need for continued investment in research, including genetics research is essential.
This fact sheet highlights how NIH-funded research and private sector innovations have led to the development of new, life-saving treatments and prevention strategies. Federal investments at NIH lay the groundwork for groundbreaking drugs and medical devices that improve the health of Americans and strengthen our economy.
This fact sheet focuses on the return on investment of funding for the National Institutes of Health. NIH research creates good jobs and benefits the economy; moreover, the treatments and therapies that result help lessen the burden of disease that affects Americans of all walks of life.